ASML Holding NV (ASML) concluded trading on Wednesday at a closing price of $712.65, with 4.96 million shares of worth about $3.53 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.14% during that period and on January 29, 2025 the price saw a gain of about 4.29%. Currently the company’s common shares owned by public are about 393.42M shares, out of which, 387.43M shares are available for trading.
Stock saw a price change of -7.05% in past 5 days and over the past one month there was a price change of -0.45%. Year-to-date (YTD), ASML shares are showing a performance of 2.82% which decreased to -17.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $645.45 but also hit the highest price of $1110.09 during that period. The average intraday trading volume for ASML Holding NV shares is 1.77 million. The stock is currently trading -2.40% below its 20-day simple moving average (SMA20), while that difference is up 0.12% for SMA50 and it goes to -15.23% lower than SMA200.
ASML Holding NV (NASDAQ: ASML) currently have 393.42M outstanding shares and institutions hold larger chunk of about 18.52% of that.
The stock has a current market capitalization of $276.27B and its 3Y-monthly beta is at 1.46. PE ratio of stock for trailing 12 months is 37.35, while it has posted earnings per share of $19.08 in the same period. Its PEG reads 1.90 and has Quick Ratio of 0.84 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ASML, volatility over the week remained 2.93% while standing at 2.43% over the month.
Stock’s fiscal year EPS is expected to rise by 19.95% while it is estimated to increase by 23.54% in next year. EPS is likely to shrink at an annualized rate of 19.61% for next 5-years, compared to annual growth of 24.50% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Exane BNP Paribas on December 03, 2024 offering an Outperform rating for the stock and assigned a target price of $858 to it. Stock get an Outperform rating from Evercore ISI on April 16, 2024.